Burzynski Research Institute (BZYR) EPS (Basic) (QoQ) (2010 - 2025)
Burzynski Research Institute (BZYR) EPS (Basic) (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Burzynski Research Institute | 1.31 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 27.89% |
| Aug 31, 2025 | 20.42% |
| May 31, 2025 | -13.20% |
| Feb 28, 2025 | -5.22% |
| Nov 30, 2024 | 4.76% |
| Aug 31, 2024 | 0.40% |
| May 31, 2024 | 17.62% |
| Feb 29, 2024 | 17.77% |
| Nov 30, 2023 | -62.80% |
| Aug 31, 2023 | -17.14% |
| May 31, 2023 | -5.12% |
| Feb 28, 2023 | 14.50% |
| Nov 30, 2022 | -17.01% |
| Aug 31, 2022 | 6.83% |
| May 31, 2022 | -35.61% |
| Feb 28, 2022 | 35.46% |
| Nov 30, 2021 | -17.83% |
| Aug 31, 2021 | 28.95% |
| May 31, 2021 | -106.50% |
| Feb 28, 2021 | 42.06% |